Depomed Reports Fourth Quarter and Full Year 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. SKYD
6. NVDA
7. CRBU
8. HALO
9. BBIO
10. SPY

Go back to Depomed Reports Fourth Quarter and Full Year 2016 Financial Results

RBC Reiterates Sector Perform Rating and $22 PT on Depomed (DEPO) Following 4Q Results, Ahead of 2/23 RBC Healthcare Conference

February 22, 2017 7:42 AM EST

RBC Capital Markets analyst Randall Stanicky reiterates Sector Perform rating and $22 price target on Depomed Inc. (NASDAQ: DEPO), suggesting the strategic outlook remains the focus, as the company reported 2016 fourth quarter revenue and EPS slightly above consensus. RBC Capital Markets will be hosting Depomed at the RBC Healthcare Conference on Thursday,... More

Depomed (DEPO) Tops Q4 EPS by 12c

February 21, 2017 4:02 PM EST

Depomed (NASDAQ: DEPO) reported Q4 EPS of $0.48, $0.12 better than the analyst estimate of $0.36. Revenue for the quarter came in at $123.9 million versus the consensus estimate of $123.28 million.

For earnings history and earnings-related data on Depomed (DEPO) click here.

... More